Lv31
400 积分 2024-06-15 加入
ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T‐Cell Lymphoblastic Leukemia/Lymphoma
4天前
已完结
[PI3K/AKT/mTOR Pathway and Pediatric T Acute Lymphoblastic Leukemia-Review]
4天前
已完结
PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response
15天前
已完结
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia
15天前
已完结
Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia
19天前
已完结
The genetics and molecular biology of T-ALL
19天前
已完结
The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes
1个月前
已完结
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
1个月前
已完结
A phase 1, open-label, multicenter, non-randomized study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of AZD4573, a potent and selective CDK9 inhibitor, in subjects with relapsed or refractory hematological malignancies
1个月前
已关闭
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)
2个月前
已完结
皖公网安备34019202002308
